Patent ductus arteriosus in the premature neonate current concepts in pharmacological management

Paediatric Drugs

Volumn 1, Issue 2, 1999, Pages 81-92

  Kaplan, Michael ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN RECEPTOR BLOCKING AGENT;

HUMAN; NEWBORN; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMATURITY; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; PROSTAGLANDIN ANTAGONISTS;

EID: 0033107549     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-199901020-00002     Document Type: Article

References (1)

1. Ellison R, Peckham G, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983; 71: 364-72